{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:40:31Z","timestamp":1791268831046,"version":"4.1.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1681\/asn.2013040425","type":"journal-article","created":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T22:28:41Z","timestamp":1398983321000},"page":"1662-1668","source":"Crossref","is-referenced-by-count":77,"title":["Administration of Recombinant Soluble Urokinase Receptor Per Se Is Not Sufficient to Induce Podocyte Alterations and Proteinuria in Mice"],"prefix":"10.1681","volume":"25","author":[{"given":"Dominique","family":"Cathelin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Placier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ploug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Verpont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Vandermeersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosu","family":"Luque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Hertig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Rondeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Mesnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20230208","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0140-6736(72)91734-5","article-title":"Recurrence of idiopathic nephrotic syndrome after renal transplantation.","volume":"2","author":"Hoyer","year":"1972","journal-title":"Lancet"},{"key":"R2-11-20230208","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1016\/S0041-1345(01)02437-X","article-title":"The Buffalo\/Mna rat, an animal model of FSGS recurrence after renal transplantation.","volume":"33","author":"Le Berre","year":"2001","journal-title":"Transplant Proc"},{"key":"R3-11-20230208","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1172\/JCI0212858","article-title":"Extrarenal effects on the pathogenesis and relapse of idiopathic nephrotic syndrome in Buffalo\/Mna rats.","volume":"109","author":"Le Berre","year":"2002","journal-title":"J Clin Invest"},{"key":"R4-11-20230208","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm1696","article-title":"Modification of kidney barrier function by the urokinase receptor.","volume":"14","author":"Wei","year":"2008","journal-title":"Nat Med"},{"key":"R5-11-20230208","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm.2411","article-title":"Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.","volume":"17","author":"Wei","year":"2011","journal-title":"Nat Med"},{"key":"R6-11-20230208","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1681\/ASN.2012030302","article-title":"Circulating suPAR in two cohorts of primary FSGS.","volume":"23","author":"Wei","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R7-11-20230208","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.2174\/092986708785909012","article-title":"The urokinase receptor and its structural homologue C4.4A in human cancer: Expression, prognosis and pharmacological inhibition.","volume":"15","author":"Jacobsen","year":"2008","journal-title":"Curr Med Chem"},{"key":"R8-11-20230208","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.2174\/138945011797635902","article-title":"uPAR as anti-cancer target: Evaluation of biomarker potential, histological localization, and antibody-based therapy.","volume":"12","author":"Lund","year":"2011","journal-title":"Curr Drug Targets"},{"key":"R9-11-20230208","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/ki.2012.32","article-title":"Serum-soluble urokinase receptor concentration in primary FSGS.","volume":"81","author":"Maas","year":"2012","journal-title":"Kidney Int"},{"key":"R10-11-20230208","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00467-013-2452-5","article-title":"Serum suPAR in patients with FSGS: Trash or treasure?","volume":"28","author":"Maas","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"R11-11-20230208","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.2215\/CJN.07680712","article-title":"Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: A single-center report.","volume":"8","author":"Bock","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"R12-11-20230208","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1182\/blood-2010-03-276642","article-title":"Selective abrogation of the uPA-uPAR interaction in vivo reveals a novel role in suppression of fibrin-associated inflammation.","volume":"116","author":"Connolly","year":"2010","journal-title":"Blood"},{"key":"R13-11-20230208","doi-asserted-by":"crossref","first-page":"10982","DOI":"10.1074\/jbc.M109.093492","article-title":"Structure-based engineering of species selectivity in the interaction between urokinase and its receptor: Implication for preclinical cancer therapy.","volume":"285","author":"Lin","year":"2010","journal-title":"J Biol Chem"},{"key":"R14-11-20230208","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrm2821","article-title":"Regulation of cell signalling by uPAR.","volume":"11","author":"Smith","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R15-11-20230208","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0014-5793(97)01491-9","article-title":"The intact urokinase receptor is required for efficient vitronectin binding: Receptor cleavage prevents ligand interaction.","volume":"420","author":"H\u00f8yer-Hansen","year":"1997","journal-title":"FEBS Lett"},{"key":"R16-11-20230208","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.2741\/3392","article-title":"Multiple activities of a multifaceted receptor: Roles of cleaved and soluble uPAR.","volume":"14","author":"Montuori","year":"2009","journal-title":"Front Biosci (Landmark Ed"},{"key":"R17-11-20230208","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1158\/1078-0432.CCR-08-0096","article-title":"Cleaved forms of the urokinase plasminogen activator receptor in plasma have diagnostic potential and predict postoperative survival in patients with ovarian cancer.","volume":"14","author":"Henic","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R18-11-20230208","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.2741\/3186","article-title":"Intact and cleaved uPAR forms: Diagnostic and prognostic value in cancer.","volume":"13","author":"Rasch","year":"2008","journal-title":"Front Biosci"},{"key":"R19-11-20230208","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.2741\/3092","article-title":"Structure and ligand interactions of the urokinase receptor (uPAR).","volume":"13","author":"Kjaergaard","year":"2008","journal-title":"Front Biosci"},{"key":"R20-11-20230208","doi-asserted-by":"crossref","first-page":"18224","DOI":"10.1016\/S0021-9258(19)37176-5","article-title":"Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain.","volume":"267","author":"H\u00f8yer-Hansen","year":"1992","journal-title":"J Biol Chem"},{"key":"R21-11-20230208","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1182\/blood.V97.10.3123","article-title":"Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: Implication for angiogenesis in fibrin matrices.","volume":"97","author":"Koolwijk","year":"2001","journal-title":"Blood"},{"key":"R22-11-20230208","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1515\/BC.2006.029","article-title":"Interplay of human tissue kallikrein 4 (hK4) with the plasminogen activation system: hK4 regulates the structure and functions of the urokinase-type plasminogen activator receptor (uPAR).","volume":"387","author":"Beaufort","year":"2006","journal-title":"Biol Chem"},{"key":"R23-11-20230208","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1083\/jcb.115.6.1763","article-title":"Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract.","volume":"115","author":"Kristensen","year":"1991","journal-title":"J Cell Biol"},{"key":"R24-11-20230208","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11010-008-9925-z","article-title":"Activated human neutrophils rapidly release the chemotactically active D2D3 form of the urokinase-type plasminogen activator receptor (uPAR\/CD87).","volume":"321","author":"Pliyev","year":"2009","journal-title":"Mol Cell Biochem"},{"key":"R25-11-20230208","doi-asserted-by":"crossref","first-page":"25992","DOI":"10.1016\/S0021-9258(18)47149-9","article-title":"The murine urokinase-type plasminogen activator receptor gene.","volume":"269","author":"Suh","year":"1994","journal-title":"J Biol Chem"},{"key":"R26-11-20230208","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1055\/s-0037-1613577","article-title":"Identification of a novel urokinase receptor splice variant and its prognostic relevance in breast cancer.","volume":"89","author":"Luther","year":"2003","journal-title":"Thromb Haemost"},{"key":"R27-11-20230208","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/(SICI)1097-4652(199908)180:2<225::AID-JCP10>3.0.CO;2-2","article-title":"Cellular glycosylphosphatidylinositol-specific phospholipase D regulates urokinase receptor shedding and cell surface expression.","volume":"180","author":"Wilhelm","year":"1999","journal-title":"J Cell Physiol"},{"key":"R28-11-20230208","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10549-010-1042-5","article-title":"Overexpression of the urokinase receptor mRNA splice variant uPAR-del4\/5 affects tumor-associated processes of breast cancer cells in vitro and in vivo.","volume":"127","author":"Sato","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"R29-11-20230208","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1432-1033.1992.tb17200.x","article-title":"A soluble form of the glycolipid-anchored receptor for urokinase-type plasminogen activator is secreted from peripheral blood leukocytes from patients with paroxysmal nocturnal hemoglobinuria.","volume":"208","author":"Ploug","year":"1992","journal-title":"Eur J Biochem"},{"key":"R30-11-20230208","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jmb.2011.12.058","article-title":"Crystal structure of the urokinase receptor in a ligand-free form.","volume":"416","author":"Xu","year":"2012","journal-title":"J Mol Biol"},{"key":"R31-11-20230208","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.exphem.2008.06.016","article-title":"Increased soluble urokinase plasminogen activator receptor (suPAR) is associated with thrombosis and inhibition of plasmin generation in paroxysmal nocturnal hemoglobinuria (PNH) patients.","volume":"36","author":"Sloand","year":"2008","journal-title":"Exp Hematol"},{"key":"R32-11-20230208","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1365-2141.1995.tb08366.x","article-title":"The receptor for urokinase plasminogen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal haemoglobinuria.","volume":"89","author":"R\u00f8nne","year":"1995","journal-title":"Br J Haematol"},{"key":"R33-11-20230208","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2141.2011.08690.x","article-title":"Management of paroxysmal nocturnal haemoglobinuria: A personal view.","volume":"153","author":"Luzzatto","year":"2011","journal-title":"Br J Haematol"},{"key":"R34-11-20230208","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ajh.21757","article-title":"Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria.","volume":"85","author":"Hillmen","year":"2010","journal-title":"Am J Hematol"},{"key":"R35-11-20230208","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2329\/perio.43.Supplement2_39","article-title":"A case of paroxysmal nocturnal hemoglobinuria combined with focal segmental glomerular sclerosis","volume":"43","author":"Takahashi","year":"2001","journal-title":"Nippon Jinzo Gakkai Shi"},{"key":"R36-11-20230208","doi-asserted-by":"crossref","first-page":"34304","DOI":"10.1074\/jbc.M112.398404","article-title":"A flexible multidomain structure drives the function of the urokinase-type plasminogen activator receptor (uPAR).","volume":"287","author":"Mertens","year":"2012","journal-title":"J Biol Chem"},{"key":"R37-11-20230208","doi-asserted-by":"crossref","first-page":"43515","DOI":"10.1074\/jbc.M111.300020","article-title":"Mimicry of the regulatory role of urokinase in lamellipodia formation by introduction of a non-native interdomain disulfide bond in its receptor.","volume":"286","author":"G\u00e5rdsvoll","year":"2011","journal-title":"J Biol Chem"},{"key":"R38-11-20230208","doi-asserted-by":"crossref","first-page":"33544","DOI":"10.1074\/jbc.M111.220087","article-title":"Conformational regulation of urokinase receptor function: impact of receptor occupancy and epitope-mapped monoclonal antibodies on lamellipodia induction.","volume":"286","author":"G\u00e5rdsvoll","year":"2011","journal-title":"J Biol Chem"},{"key":"R39-11-20230208","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nm0209-133a","article-title":"Is the LPS-mediated proteinuria mouse model relevant to human kidney disease?","volume":"15","author":"Comper","year":"2009","journal-title":"Nat Med"},{"key":"R40-11-20230208","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/ndt\/gfn574","article-title":"Sirolimus interacts with pathways essential for podocyte integrity.","volume":"24","author":"Letavernier","year":"2009","journal-title":"Nephrol Dial Transplant"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201408000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:24:15Z","timestamp":1786130655000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201408000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2013040425","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718370915.793530389","asserted-by":"object"}]},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}